Literature DB >> 20354241

Are Hong Kong doctors following the Global Initiative for Asthma guidelines: a questionnaire "Survey on Asthma Management"?

F W S Ko1, A M W Chan, H S Chan, A Y F Kong, R C C Leung, T Y W Mok, H H Tse, C K W Lai.   

Abstract

OBJECTIVE: To assess the standard of asthma management by doctors in Hong Kong.
DESIGN: Cross-sectional postal questionnaire survey.
SETTING: Hong Kong. PARTICIPANTS: Practising doctors registered with the Medical Council of Hong Kong were sent a questionnaire between August and December 2007. MAIN OUTCOME MEASURES: Respondents' responses to questions on demographic data, parameters routinely used to assess asthma control, the pattern of asthma medication prescribing, and seven different case scenarios assessing their ability to classify asthma control and management. RESULTS. We received 410 completed questionnaires from general practitioners (55%), internists (22%), paediatricians (11%), and other specialists (12%). The majority (82%) explained the pathology of asthma to at least some of their patients and tried to identify aggravating factors of the asthma (91%). Fewer observed the inhalation technique of their patients (68%) and prescribed a written asthma management plan (33%). The main medications prescribed to adults and children with asthma were inhaled corticosteroids, inhaled short-acting beta-2 agonists, and combinations of an inhaled corticosteroid and a long-acting beta-2 agonist. In adults and children, long-acting beta-2 agonist alone (without inhaled corticosteroid) was being used to treat asthma by 45% and 36% of the doctors, respectively. Also, 94% of the respondents correctly classified the control status in four out of the seven case scenarios and 31% chose the correct medications when responding to seven of the 14 questions asked.
CONCLUSIONS: Asthma management practice of Hong Kong doctors falls short of the standards recommended by international guidelines. More effort in improving their knowledge is urgently warranted.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20354241

Source DB:  PubMed          Journal:  Hong Kong Med J        ISSN: 1024-2708            Impact factor:   2.227


  6 in total

1.  Cost considerations of therapeutic options for children with asthma.

Authors:  Sandra Chuang; Adam Jaffe
Journal:  Paediatr Drugs       Date:  2012-08-01       Impact factor: 3.022

Review 2.  Clinical practice guideline dissemination and a new approach using Haddon matrix as a conceptual framework of evidence-based implementation strategies.

Authors:  Peter Pang
Journal:  World J Emerg Med       Date:  2010

3.  Prescription of oral short-acting beta 2-agonist for asthma in non-resource poor settings: A national study in Malaysia.

Authors:  May Chien Chin; Sheamini Sivasampu; Ee Ming Khoo
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

4.  Implementation of GINA guidelines in asthma management by primary care physicians in Vietnam.

Authors:  Vinh Nhu Nguyen; Quynh Nhat Nguyen; Pham Le An; Niels H Chavannes
Journal:  Int J Gen Med       Date:  2017-10-05

5.  Indicadores do uso de medicamentos na atenção primária de saúde: uma revisão sistemática.

Authors:  André Santos da Silva; Gabriella de Alcantara Maciel; Luciane Soares de Lima Wanderley; Almir Gonçalves Wanderley
Journal:  Rev Panam Salud Publica       Date:  2017-11-11

6.  The attitude, knowledge, and behavior of family physicians about childhood asthma in Sakarya province.

Authors:  Nezihe Nefise Uluç; Öner Özdemir
Journal:  Turk Pediatri Ars       Date:  2019-12-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.